source
- Novo Nordisk seeks injunction to halt Eli Lilly's obesity drug adsNovo Nordisk filed a motion in a New Jersey federal court asking for a preliminary injunction that would stop Eli Lilly's advertisements for its obesity treatments. Novo claims the ads are mislead…
- Summit Therapeutics faces under a year of cash runway as FDA decision on ivonescimab loomsSummit Therapeutics reported that its cash and short-term investments total just over $690 million, which the company says is insufficient to fund operations for a full year. The biotech’s lead ca…